Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.01 billion.
Market Cap
1.12T
Revenue
110.01B
Profits
-41.28B
PE Ratio
n/a
Profit Margin
-37.52%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.03B | 0.72% | 1,395,086 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 65.38B | -1.10% | 1,178,480 | 14.92B |
| 3 | ARGX | argenx SE | 50.88B | 1.49% | 429,771 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.12B | 0.68% | 650,227 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.42B | 0.29% | 246,298 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.68B | 2.26% | 1,846,182 | - |
| 7 | RPRX | Royalty Pharma plc | 30.84B | 0.92% | 2,826,461 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.74B | 1.50% | 3,689,970 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.99B | 0.63% | 958,080 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.21B | -4.72% | 10,111,381 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.46B | 0.34% | 765,519 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.75B | -1.79% | 4,787,357 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.39B | -0.59% | 1,050,389 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.37B | 2.56% | 410,268 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.02B | 0.16% | 596,118 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.77B | 3.02% | 2,284,549 | 579.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 13.56B | -2.35% | 3,373,882 | - |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.52B | 0.96% | 2,295,135 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.48B | -0.50% | 1,485,824 | 2.38B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.02B | 1.31% | 590,616 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.02% | 203,583 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.64B | -2.07% | 1,580,121 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.60B | -0.90% | 1,775,131 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | 7.77% | 4,570,994 | 3.24B |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 4.45% | 286,383 | 7.46M |
| 26 | ABVX | ABIVAX Société Anonyme | 9.70B | 3.44% | 1,665,957 | 5.37M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.97B | 0.72% | 171,299 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -0.67% | 1,750,693 | 1.51B |
| 29 | IBRX | ImmunityBio, Inc. | 8.11B | -3.85% | 21,526,585 | 140.98M |
| 30 | NUVL | Nuvalent, Inc. | 8.00B | -1.06% | 372,019 | - |
| 31 | TECH | Bio-Techne Corporation | 7.42B | 1.43% | 2,315,428 | 1.21B |
| 32 | IMVT | Immunovant, Inc. | 7.01B | -4.02% | 4,607,804 | - |
| 33 | CELC | Celcuity Inc. | 6.95B | 1.56% | 660,702 | - |
| 34 | PCVX | Vaxcyte, Inc. | 6.84B | 0.47% | 1,180,257 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.63B | -0.05% | 407,642 | 51.48M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.56B | 1.12% | 402,918 | 74.06M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.45B | 3.34% | 738,432 | - |
| 38 | CORT | Corcept Therapeutics Incorporated | 6.41B | 1.07% | 874,619 | 769.10M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.18B | -0.50% | 539,529 | 217.17M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.18B | 1.28% | 369,946 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.15% | 1,745,330 | 15.00M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 3.84% | 922,851 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.79B | -1.73% | 808,821 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.72B | -1.36% | 1,051,979 | - |
| 45 | CGON | CG Oncology, Inc. | 5.70B | -0.26% | 685,251 | 5.07M |
| 46 | BLTE | Belite Bio, Inc | 5.67B | 0.62% | 134,304 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.57B | -1.06% | 1,576,744 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 5.56B | -1.31% | 1,265,178 | 700.35M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.23B | -1.02% | 1,148,603 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.20B | -0.46% | 1,535,747 | 1.14B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.90B | 1.03% | 514,505 | 1.34M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.81B | 2.78% | 1,445,872 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.51B | 1.53% | 2,455,760 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | 2.03% | 153,804 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.31B | -0.59% | 295,324 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.18B | -0.22% | 1,059,860 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.16B | 2.87% | 1,325,392 | 536.20M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.91B | 2.26% | 740,781 | 18.07M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.10% | 2,343,765 | 596.96M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.65B | 1.77% | 1,640,419 | 1.10B |
| 61 | ERAS | Erasca, Inc. | 3.61B | 4.36% | 3,109,077 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.56B | 4.21% | 2,003,122 | - |
| 63 | ORKA | Oruka Therapeutics, Inc. | 3.54B | -3.26% | 1,287,988 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -0.40% | 639,845 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.42B | -0.10% | 107,488 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.13B | 2.56% | 2,578,502 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.06B | 2.50% | 1,351,506 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.00B | 0.55% | 405,610 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.87B | -1.08% | 1,773,481 | - |
| 70 | ALMS | Alumis Inc. | 2.83B | 0.59% | 874,022 | 8.40M |
| 71 | GPCR | Structure Therapeutics Inc. | 2.76B | 5.21% | 500,313 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.75B | 2.07% | 1,980,318 | 164.01M |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.73B | -2.02% | 293,733 | 535.08M |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.73B | 4.98% | 362,106 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.63B | 2.66% | 1,375,272 | 415.62M |
| 76 | RLAY | Relay Therapeutics, Inc. | 2.62B | 4.92% | 10,419,234 | 10.68M |
| 77 | IMNM | Immunome, Inc. | 2.60B | 6.64% | 1,586,305 | 4.02M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.60B | -0.37% | 642,470 | 225.27M |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.57B | 0.93% | 918,325 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.56B | 0.15% | 341,471 | - |
| 81 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | 6.33% | 907,767 | - |
| 82 | DFTX | Definium Therapeutics, Inc. | 2.47B | 8.53% | 2,116,306 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.47B | -0.77% | 527,711 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.40B | -1.04% | 904,362 | 865.00K |
| 85 | KOD | Kodiak Sciences Inc. | 2.34B | 3.29% | 464,012 | - |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 1.45% | 1,272,123 | 670.00M |
| 87 | NKTR | Nektar Therapeutics | 2.31B | -1.31% | 585,431 | 55.63M |
| 88 | ZLAB | Zai Lab Limited | 2.15B | 1.54% | 427,466 | 453.28M |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.01B | 2.02% | 957,430 | - |
| 90 | PHVS | Pharvaris N.V. | 2.00B | 3.70% | 308,788 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -2.83% | 919,930 | 298.30M |
| 92 | TYRA | Tyra Biosciences, Inc. | 1.96B | -1.23% | 609,654 | - |
| 93 | ADMA | ADMA Biologics, Inc. | 1.96B | -1.17% | 3,345,193 | 509.86M |
| 94 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 0.34% | 1,530,690 | 70.92M |
| 95 | MESO | Mesoblast Limited | 1.91B | 3.17% | 144,312 | 65.38M |
| 96 | AAPG | Ascentage Pharma Group International | 1.90B | 4.45% | 4,829 | 82.08M |
| 97 | SION | Sionna Therapeutics, Inc. | 1.89B | 5.70% | 236,749 | - |
| 98 | NBTX | Nanobiotix S.A. | 1.88B | -6.90% | 111,303 | 38.27M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.85B | -2.08% | 487,951 | 32.08M |
| 100 | OCS | Oculis Holding AG | 1.83B | 11.07% | 965,803 | 1.40M |
| 101 | ZYME | Zymeworks Inc. | 1.83B | 1.09% | 618,617 | 81.26M |
| 102 | LKFT | Lakefront Biotherapeutics NV | 1.83B | 1.39% | 193,846 | 1.20B |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 6.76% | 1,956,355 | 71.78M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.80B | 2.37% | 2,313,251 | 52.04M |
| 105 | VCEL | Vericel Corporation | 1.80B | -0.71% | 1,071,925 | 292.09M |
| 106 | GENB | Generate Biomedicines, Inc. | 1.79B | 7.37% | 997,822 | 30.30M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | -0.93% | 2,020,606 | 2.18B |
| 108 | HRMY | Harmony Biosciences Holdings, Inc. | 1.77B | -2.84% | 586,240 | 899.11M |
| 109 | ANAB | AnaptysBio, Inc. | 1.76B | 0.55% | 396,310 | 232.39M |
| 110 | RAPP | Rapport Therapeutics, Inc. | 1.76B | 2.74% | 321,008 | 20.00M |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -1.79% | 1,204,951 | 217.17M |
| 112 | NTLA | Intellia Therapeutics, Inc. | 1.73B | 0.90% | 4,433,683 | 66.09M |
| 113 | CAPR | Capricor Therapeutics, Inc. | 1.71B | 1.96% | 893,275 | 11.13M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.02% | 522,741 | 66.05M |
| 115 | NUVB | Nuvation Bio Inc. | 1.67B | 6.21% | 4,094,775 | 143.05M |
| 116 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 0.54% | 168,062 | - |
| 117 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 4.52% | 10,607,681 | 285.61M |
| 118 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | 5.07% | 13,141,097 | 66.41M |
| 119 | INVA | Innoviva, Inc. | 1.64B | -0.18% | 815,097 | 420.69M |
| 120 | INBX | Inhibrx Biosciences, Inc. | 1.62B | 0.51% | 335,104 | 1.30M |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | 1.23% | 758,631 | 42.95M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | 0.91% | 2,208,750 | 7.47M |
| 123 | ATAI | AtaiBeckley Inc. | 1.59B | 5.87% | 4,028,890 | 3.49M |
| 124 | ABCL | AbCellera Biologics Inc. | 1.57B | 12.47% | 13,942,911 | 79.21M |
| 125 | ARDX | Ardelyx, Inc. | 1.57B | 1.28% | 2,927,620 | 427.68M |
| 126 | QURE | uniQure N.V. | 1.56B | 0.65% | 1,012,820 | 18.09M |
| 127 | IMCR | Immunocore Holdings plc | 1.53B | 1.56% | 243,992 | 412.81M |
| 128 | PGEN | Precigen, Inc. | 1.53B | 0.23% | 2,242,301 | 31.60M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.52B | 1.69% | 957,350 | 65.50M |
| 130 | MBX | MBX Biosciences, Inc. | 1.51B | 1.15% | 460,318 | - |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.50B | 2.94% | 255,271 | - |
| 132 | GHRS | GH Research PLC | 1.49B | -3.42% | 310,061 | - |
| 133 | IMTX | Immatics N.V. | 1.48B | -1.38% | 408,343 | 43.00M |
| 134 | NVAX | Novavax, Inc. | 1.48B | -3.13% | 3,591,625 | 596.34M |
| 135 | URGN | UroGen Pharma Ltd. | 1.46B | -1.13% | 789,735 | 140.49M |
| 136 | BHVN | Biohaven Ltd. | 1.43B | 7.12% | 2,157,847 | - |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.15% | 1,645,105 | 114.48M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.43B | 2.88% | 440,145 | 20.00M |
| 139 | SLS | SELLAS Life Sciences Group, Inc. | 1.41B | -15.72% | 25,101,743 | - |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.37B | 2.01% | 429,537 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.35B | 8.33% | 926,160 | - |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.33B | 5.29% | 158,904 | - |
| 143 | SVRA | Savara Inc. | 1.28B | -0.39% | 965,669 | - |
| 144 | SEPN | Septerna, Inc. | 1.26B | -0.32% | 232,417 | 72.26M |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.26B | -0.81% | 475,357 | - |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 1.43% | 531,481 | 10.00M |
| 147 | FTRE | Fortrea Holdings Inc. | 1.24B | -4.09% | 1,115,850 | 2.71B |
| 148 | WVE | Wave Life Sciences Ltd. | 1.24B | 3.72% | 3,669,090 | 71.80M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | 0.72% | 1,081,258 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.19B | 1.36% | 240,436 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -0.64% | 193,386 | - |
| 152 | JBIO | Jade Biosciences, Inc. | 1.16B | 0.54% | 368,826 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.16B | 1.13% | 2,633,718 | 204.73M |
| 154 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 7.30% | 1,891,807 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.10B | 0.16% | 167,113 | 5.74M |
| 156 | EYPT | EyePoint, Inc. | 1.07B | 2.24% | 559,607 | 7.61M |
| 157 | IVA | Inventiva S.A. | 1.06B | 1.36% | 119,433 | 7.94M |
| 158 | AKTS | Aktis Oncology, Inc. | 1.06B | 0.47% | 147,601 | 8.28M |
| 159 | MNKD | MannKind Corporation | 1.02B | 1.85% | 3,001,293 | 360.78M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.35M | 0.90% | 1,688,464 | 69.64M |
| 161 | KURA | Kura Oncology, Inc. | 988.06M | 7.64% | 5,224,175 | 71.64M |
| 162 | DRTS | Alpha Tau Medical Ltd. | 964.59M | -1.97% | 731,749 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 919.80M | -2.44% | 662,283 | 204.89M |
| 164 | PHAR | Pharming Group N.V. | 915.65M | -0.47% | 6,056 | 369.49M |
| 165 | SPTX | Seaport Therapeutics, Inc. | 911.55M | 8.94% | 209,797 | - |
| 166 | ANNX | Annexon, Inc. | 891.30M | 7.94% | 3,011,963 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 878.86M | -0.94% | 411,108 | 79.76M |
| 168 | JANX | Janux Therapeutics, Inc. | 878.78M | 0.21% | 633,806 | 13.73M |
| 169 | ABUS | Arbutus Biopharma Corporation | 877.07M | 1.60% | 2,357,570 | 191.45M |
| 170 | SANA | Sana Biotechnology, Inc. | 876.62M | 1.29% | 2,069,163 | - |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 875.76M | 0.59% | 626,118 | - |
| 172 | OMER | Omeros Corporation | 865.61M | -3.39% | 1,095,886 | 9.89M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 859.18M | -2.44% | 705,542 | - |
| 174 | EVMN | Evommune, Inc. | 848.23M | 5.70% | 604,322 | 10.00M |
| 175 | AURA | Aura Biosciences, Inc. | 843.79M | 2.41% | 898,691 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 842.38M | -1.33% | 269,436 | 109.78M |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 836.87M | 4.54% | 408,066 | 2.98M |
| 178 | XNCR | Xencor, Inc. | 835.58M | -0.44% | 642,633 | 97.36M |
| 179 | CTMX | CytomX Therapeutics, Inc. | 818.56M | 1.08% | 1,597,194 | 35.54M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 818.12M | 0.56% | 517,766 | - |
| 181 | SPRY | ARS Pharmaceuticals, Inc. | 817.27M | 5.51% | 2,126,691 | 98.99M |
| 182 | VOR | Vor Biopharma Inc. | 814.95M | -3.28% | 1,038,522 | - |
| 183 | AVTX | Avalo Therapeutics, Inc. | 814.34M | 1.90% | 1,363,536 | 59.00K |
| 184 | GERN | Geron Corporation | 808.32M | - | 8,149,682 | 196.12M |
| 185 | LBRX | LB Pharmaceuticals Inc | 802.95M | -0.11% | 156,076 | - |
| 186 | ABSI | Absci Corporation | 793.56M | 2.83% | 2,608,308 | 1.84M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 756.24M | 0.56% | 723,015 | - |
| 188 | ANRO | Alto Neuroscience, Inc. | 755.04M | 3.66% | 263,926 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 737.06M | 0.73% | 79,866 | - |
| 190 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 729.10M | 3.41% | 496,973 | - |
| 191 | TENX | Tenax Therapeutics, Inc. | 727.74M | 3.00% | 443,410 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 687.65M | -0.81% | 1,127,464 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 676.50M | 3.16% | 4,333,895 | 22.00K |
| 194 | CBIO | Crescent Biopharma, Inc. | 672.22M | 6.98% | 249,462 | 11.88M |
| 195 | SLDB | Solid Biosciences Inc. | 639.92M | 0.46% | 742,771 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 634.07M | 0.22% | 480,799 | 8.37M |
| 197 | CRMD | CorMedix Inc. | 632.32M | 1.64% | 1,386,252 | 400.05M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 620.12M | 2.44% | 2,441,269 | 122.29M |
| 199 | EIKN | Eikon Therapeutics, Inc. | 605.81M | 4.97% | 185,201 | - |
| 200 | CABA | Cabaletta Bio, Inc. | 601.65M | 7.27% | 3,601,435 | - |
| 201 | ARVN | Arvinas, Inc. | 587.14M | - | 782,348 | 89.40M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 584.80M | 3.65% | 307,200 | - |
| 203 | CADL | Candel Therapeutics, Inc. | 581.03M | 2.85% | 1,671,461 | - |
| 204 | ALT | Altimmune, Inc. | 569.81M | 3.90% | 3,062,637 | 36.00K |
| 205 | GYRE | Gyre Therapeutics, Inc. | 564.68M | 2.32% | 97,441 | 117.05M |
| 206 | VALN | Valneva SE | 543.39M | -0.84% | 11,744 | 180.25M |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 540.08M | 1.28% | 214,864 | 299.77M |
| 208 | CTNM | Contineum Therapeutics, Inc. | 539.49M | 7.77% | 155,856 | - |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 538.72M | 3.85% | 822,528 | - |
| 210 | TECX | Tectonic Therapeutic, Inc. | 538.15M | -1.28% | 103,169 | - |
| 211 | MDXG | MiMedx Group, Inc. | 537.69M | -4.75% | 1,474,294 | 389.42M |
| 212 | FBRX | Forte Biosciences, Inc. | 537.58M | 8.67% | 227,732 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 535.82M | 1.68% | 27,861 | - |
| 214 | PRME | Prime Medicine, Inc. | 532.82M | 4.24% | 1,995,446 | 4.03M |
| 215 | PROK | ProKidney Corp. | 528.43M | 3.55% | 876,519 | 889.00K |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.82M | 4.66% | 654,346 | 151.40M |
| 217 | XOMA | XOMA Royalty Corporation | 524.47M | -0.38% | 52,217 | 48.56M |
| 218 | CLYM | Climb Bio, Inc. | 521.15M | 3.71% | 604,048 | - |
| 219 | STRO | Sutro Biopharma, Inc. | 507.31M | -1.64% | 364,695 | 99.61M |
| 220 | PRTA | Prothena Corporation plc | 492.64M | 0.64% | 388,741 | 57.94M |
| 221 | ACHV | Achieve Life Sciences, Inc. | 472.23M | 0.66% | 841,575 | - |
| 222 | ANL | Adlai Nortye Ltd. | 462.40M | 6.34% | 96,476 | 5.00M |
| 223 | UPB | Upstream Bio, Inc. | 460.39M | 0.59% | 597,539 | 3.32M |
| 224 | STTK | Shattuck Labs, Inc. | 460.29M | -1.30% | 1,014,880 | 1.00M |
| 225 | IMMX | Immix Biopharma, Inc. | 459.61M | -3.02% | 5,932,409 | - |
| 226 | OCGN | Ocugen, Inc. | 457.00M | -0.74% | 4,140,382 | 4.47M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 454.28M | 2.60% | 555,179 | 88.24M |
| 228 | VTVT | vTv Therapeutics Inc. | 440.54M | -5.14% | 25,110 | 36.84M |
| 229 | AUTL | Autolus Therapeutics plc | 439.14M | 1.85% | 667,605 | 92.62M |
| 230 | FULC | Fulcrum Therapeutics, Inc. | 439.11M | 4.02% | 402,630 | 80.00M |
| 231 | NGNE | Neurogene Inc. | 436.29M | 2.45% | 135,591 | 925.00K |
| 232 | PRLD | Prelude Therapeutics Incorporated | 435.50M | -3.78% | 220,604 | 16.72M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.07M | 8.95% | 414,261 | - |
| 234 | ADCT | ADC Therapeutics SA | 432.45M | 4.94% | 862,217 | 79.18M |
| 235 | SGMT | Sagimet Biosciences Inc. | 432.26M | 5.26% | 776,428 | - |
| 236 | REPL | Replimune Group, Inc. | 431.03M | 1.16% | 4,557,499 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 422.21M | 2.09% | 727,864 | 7.12M |
| 238 | ZURA | Zura Bio Limited | 421.27M | 8.69% | 879,646 | - |
| 239 | ASMB | Assembly Biosciences, Inc. | 419.88M | 0.61% | 63,893 | 71.10M |
| 240 | MNPR | Monopar Therapeutics Inc. | 419.88M | -3.49% | 158,015 | - |
| 241 | LXEO | Lexeo Therapeutics, Inc. | 410.67M | 2.15% | 666,228 | - |
| 242 | IPSC | Century Therapeutics, Inc. | 409.40M | 0.89% | 499,144 | 109.16M |
| 243 | LYEL | Lyell Immunopharma, Inc. | 403.65M | 0.46% | 69,805 | 31.00K |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 402.15M | 1.62% | 141,618 | 69.21M |
| 245 | BNTC | Benitec Biopharma Inc. | 390.27M | 3.37% | 43,659 | - |
| 246 | ARTV | Artiva Biotherapeutics, Inc. | 388.22M | 1.91% | 424,740 | 251.00K |
| 247 | CCCC | C4 Therapeutics, Inc. | 387.84M | 7.32% | 2,128,564 | 34.86M |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 381.05M | 7.16% | 254,734 | 9.01M |
| 249 | GLSI | Greenwich LifeSciences, Inc. | 376.70M | -0.48% | 67,908 | - |
| 250 | VSTM | Verastem, Inc. | 375.22M | 3.39% | 2,940,028 | 49.59M |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 373.44M | 0.49% | 748,664 | 217.78M |
| 252 | LRMR | Larimar Therapeutics, Inc. | 372.65M | 1.13% | 1,516,758 | - |
| 253 | OABI | OmniAb, Inc. | 369.68M | -1.16% | 624,437 | 28.94M |
| 254 | IFRX | InflaRx N.V. | 363.81M | 1.23% | 505,143 | 33.82K |
| 255 | PBYI | Puma Biotechnology, Inc. | 358.84M | 0.86% | 175,078 | 227.18M |
| 256 | RGNX | REGENXBIO Inc. | 348.96M | 13.07% | 2,972,652 | 87.82M |
| 257 | RZLT | Rezolute, Inc. | 348.92M | 3.73% | 865,314 | - |
| 258 | CMPX | Compass Therapeutics, Inc. | 347.57M | 2.12% | 6,576,810 | 850.00K |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 346.33M | 2.26% | 211,531 | 51.00M |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 339.59M | 4.71% | 2,848,323 | - |
| 261 | AVIR | Atea Pharmaceuticals, Inc. | 339.31M | 1.19% | 411,731 | - |
| 262 | NMRA | Neumora Therapeutics, Inc. | 337.97M | 7.56% | 1,593,792 | - |
| 263 | IMRX | Immuneering Corporation | 337.72M | 3.98% | 1,025,545 | - |
| 264 | PALI | Palisade Bio, Inc. | 336.52M | 6.91% | 5,897,320 | - |
| 265 | LCTX | Lineage Cell Therapeutics, Inc. | 329.07M | 2.33% | 586,400 | 14.78M |
| 266 | IVVD | Invivyd, Inc. | 327.01M | 1.83% | 2,877,245 | 55.87M |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 322.78M | 6.72% | 528,561 | - |
| 268 | YDES | YD Bio Limited | 317.85M | -0.66% | 6,179 | 510.36K |
| 269 | ABEO | Abeona Therapeutics Inc. | 314.61M | 3.76% | 801,299 | 14.54M |
| 270 | SRZN | Surrozen, Inc. | 311.17M | 0.15% | 46,695 | 7.49M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 310.91M | 0.87% | 109,728 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 310.20M | 0.68% | 389,443 | 63.50M |
| 273 | SLN | Silence Therapeutics plc | 306.55M | 4.01% | 130,140 | 839.00K |
| 274 | IRD | Opus Genetics, Inc. | 306.32M | -3.38% | 649,304 | 11.98M |
| 275 | NAGE | Niagen Bioscience, Inc. | 302.48M | 1.07% | 927,181 | 130.42M |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 302.00M | 1.35% | 44,986 | 5.20M |
| 277 | ELDN | Eledon Pharmaceuticals, Inc. | 300.71M | 1.30% | 928,471 | - |
| 278 | NGEN | NervGen Pharma Corp. | 297.83M | -1.60% | 593,910 | - |
| 279 | IKT | Inhibikase Therapeutics, Inc. | 296.53M | 3.57% | 977,105 | 1.00 |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 294.71M | 11.59% | 864,756 | 26.87M |
| 281 | NVCT | Nuvectis Pharma, Inc. | 290.19M | 2.92% | 99,061 | - |
| 282 | ACIU | AC Immune SA | 282.72M | -1.38% | 146,700 | 4.62M |
| 283 | TARA | Protara Therapeutics, Inc. | 279.34M | 4.41% | 2,516,132 | - |
| 284 | MGNX | MacroGenics, Inc. | 269.49M | -4.93% | 870,662 | 157.08M |
| 285 | ALXO | ALX Oncology Holdings Inc. | 267.77M | - | 531,152 | - |
| 286 | SABS | SAB Biotherapeutics, Inc. | 267.75M | 3.53% | 373,520 | 114.70K |
| 287 | EDIT | Editas Medicine, Inc. | 261.41M | 2.69% | 976,754 | 38.69M |
| 288 | CLLS | Cellectis S.A. | 257.53M | -3.83% | 34,449 | 75.11M |
| 289 | AVXL | Anavex Life Sciences Corp. | 251.14M | -1.45% | 954,698 | - |
| 290 | ADAG | Adagene Inc. | 250.42M | 9.86% | 147,328 | 7.67M |
| 291 | NERV | Minerva Neurosciences, Inc. | 246.92M | 5.37% | 225,570 | - |
| 292 | CGEN | Compugen Ltd. | 246.87M | -3.51% | 541,388 | 72.66M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 245.51M | 3.02% | 287,657 | 32.72M |
| 294 | ALEC | Alector, Inc. | 245.37M | 4.25% | 929,675 | 18.42M |
| 295 | FATE | Fate Therapeutics, Inc. | 244.77M | 14.13% | 5,355,641 | 6.32M |
| 296 | FHTX | Foghorn Therapeutics Inc. | 244.25M | 4.00% | 126,711 | 28.22M |
| 297 | CHRS | Coherus Oncology, Inc. | 242.17M | 3.97% | 1,393,061 | 46.88M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 235.79M | 4.44% | 631,557 | 20.99M |
| 299 | HELP | Cybin Inc. | 230.16M | 5.99% | 1,063,161 | - |
| 300 | CDXS | Codexis, Inc. | 229.97M | -1.94% | 694,910 | 78.09M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 228.47M | -2.22% | 60,660 | 3.93M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 227.37M | 4.47% | 371,884 | 5.74M |
| 303 | HUMA | Humacyte, Inc. | 226.46M | 11.21% | 6,802,234 | 2.02M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 223.30M | 4.63% | 63,554 | 19.39M |
| 305 | TNXP | Tonix Pharmaceuticals Holding Corp. | 223.17M | -3.45% | 358,981 | 17.56M |
| 306 | RNA | Atrium Therapeutics, Inc. | 223.06M | 2.59% | 252,364 | 36.68M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 222.35M | 5.14% | 444,957 | 36.49M |
| 308 | KROS | Keros Therapeutics, Inc. | 221.67M | 2.00% | 384,130 | 33.18M |
| 309 | CNTX | Context Therapeutics Inc. | 220.51M | 7.62% | 986,894 | - |
| 310 | NKTX | Nkarta, Inc. | 216.78M | 8.21% | 578,991 | - |
| 311 | MDWD | MediWound Ltd. | 216.43M | -0.30% | 30,730 | 16.96M |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 212.54M | 1.90% | 164,889 | 7.15M |
| 313 | MIST | Milestone Pharmaceuticals Inc. | 206.80M | 1.33% | 1,011,797 | 1.78M |
| 314 | NBP | NovaBridge Biosciences | 205.85M | 1.14% | 503,996 | - |
| 315 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 204.15M | 18.29% | 651,666 | - |
| 316 | UNCY | Unicycive Therapeutics, Inc. | 203.72M | -1.42% | 598,340 | - |
| 317 | BDTX | Black Diamond Therapeutics, Inc. | 203.42M | -1.39% | 5,284,927 | 70.00M |
| 318 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.53M | 2.93% | 341,082 | 54.71M |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 196.27M | 2.45% | 126,339 | 1.78M |
| 320 | IPHA | Innate Pharma S.A. | 195.68M | -10.45% | 48,777 | 10.57M |
| 321 | CRBU | Caribou Biosciences, Inc. | 195.54M | -0.50% | 1,368,148 | 11.20M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 189.80M | 3.08% | 263,135 | - |
| 323 | PLYX | Polaryx Therapeutics, Inc. | 186.53M | 16.57% | 323,861 | - |
| 324 | TLSA | Tiziana Life Sciences Ltd | 186.33M | -9.32% | 1,145,911 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 184.49M | -0.42% | 129,599 | 45.07M |
| 326 | ELTX | Elicio Therapeutics, Inc. | 182.12M | -0.70% | 113,659 | - |
| 327 | KPTI | Karyopharm Therapeutics Inc. | 181.76M | 1.00% | 517,765 | 151.12M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 179.85M | 5.96% | 411,469 | - |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 177.15M | 2.34% | 82,304 | 2.00M |
| 330 | ANTX | AN2 Therapeutics, Inc. | 176.02M | 6.54% | 101,829 | - |
| 331 | ENLV | Enlivex Ltd. | 173.60M | 2.37% | 126,918 | - |
| 332 | TNYA | Tenaya Therapeutics, Inc. | 171.43M | -2.24% | 2,525,799 | 225.00K |
| 333 | IMUX | Immunic, Inc. | 167.54M | 6.49% | 262,505 | - |
| 334 | GALT | Galectin Therapeutics Inc. | 165.89M | 14.03% | 391,523 | - |
| 335 | HRTX | Heron Therapeutics, Inc. | 164.90M | 3.09% | 1,293,229 | 150.71M |
| 336 | OKUR | OnKure Therapeutics, Inc. | 164.41M | 14.33% | 295,154 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 163.56M | 1.00% | 873,603 | 76.38M |
| 338 | KRRO | Korro Bio, Inc. | 161.53M | 11.89% | 278,176 | 3.84M |
| 339 | MENS | Jyong Biotech Ltd. | 159.95M | -4.15% | 19,252 | - |
| 340 | SPRO | Spero Therapeutics, Inc. | 155.76M | 2.28% | 433,214 | 61.19M |
| 341 | PRQR | ProQR Therapeutics N.V. | 151.72M | 0.70% | 777,430 | 15.73M |
| 342 | KZIA | Kazia Therapeutics Limited | 150.49M | 1.54% | 170,370 | 1.27M |
| 343 | HURA | TuHURA Biosciences, Inc. | 149.02M | -2.09% | 374,677 | - |
| 344 | TTRX | Turn Therapeutics Inc. | 148.05M | 4.41% | 112,754 | - |
| 345 | GUTS | Fractyl Health, Inc. | 145.96M | -0.14% | 1,549,700 | 3.00K |
| 346 | SPRB | Spruce Biosciences, Inc. | 142.41M | 2.29% | 51,488 | 697.00K |
| 347 | EQ | Equillium, Inc. | 139.73M | 7.28% | 276,063 | 4.39M |
| 348 | MOLN | Molecular Partners AG | 136.52M | 1.60% | 18,104 | 856.30K |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 135.01M | -1.11% | 18,457 | 39.99K |
| 350 | CNTB | Connect Biopharma Holdings Limited | 133.39M | 2.16% | 115,859 | 233.00K |
| 351 | AGEN | Agenus Inc. | 131.26M | 0.32% | 434,684 | 123.87M |
| 352 | GNLX | Genelux Corporation | 129.67M | -0.34% | 51,503 | 8.00K |
| 353 | ACOG | Alpha Cognition Inc. | 126.73M | -1.53% | 23,654 | 10.83M |
| 354 | PYXS | Pyxis Oncology, Inc. | 122.91M | -3.00% | 351,402 | 13.86M |
| 355 | CRDF | Cardiff Oncology, Inc. | 122.38M | -2.72% | 1,539,459 | 525.00K |
| 356 | KLRS | Kalaris Therapeutics, Inc. | 117.72M | 6.00% | 34,160 | - |
| 357 | ALPS | Alps Group Inc | 116.48M | 2.07% | 16,033 | 3.74M |
| 358 | ENGN | enGene Therapeutics Inc. | 115.89M | 7.45% | 1,767,193 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 113.53M | 4.76% | 99,962 | 7.94M |
| 360 | CGTX | Cognition Therapeutics, Inc. | 111.69M | -3.10% | 906,032 | - |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 108.98M | 8.13% | 3,450,086 | 65.34K |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 106.80M | -1.83% | 1,032,724 | 3.17M |
| 363 | PEPG | PepGen Inc. | 106.52M | 6.94% | 732,354 | - |
| 364 | CBUS | Cibus, Inc. | 105.27M | -2.82% | 146,486 | 4.29M |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 101.35M | -1.99% | 35,398 | 37.16M |
| 366 | NRXP | NRx Pharmaceuticals, Inc. | 101.09M | 3.03% | 1,023,611 | 2.29M |
| 367 | VANI | Vivani Medical, Inc. | 100.03M | -2.52% | 236,491 | - |
| 368 | SEER | Seer, Inc. | 99.86M | 5.36% | 215,433 | 15.17M |
| 369 | BMEA | Biomea Fusion, Inc. | 99.05M | 3.01% | 777,835 | - |
| 370 | AARD | Aardvark Therapeutics, Inc. | 98.39M | 5.13% | 166,493 | - |
| 371 | PMN | ProMIS Neurosciences, Inc. | 97.30M | 2.36% | 21,264 | - |
| 372 | EDSA | Edesa Biotech, Inc. | 96.59M | -0.55% | 210,030 | - |
| 373 | ALDX | Aldeyra Therapeutics, Inc. | 95.91M | 2.58% | 628,918 | - |
| 374 | LONA | LeonaBio, Inc. | 94.59M | 4.68% | 193,236 | - |
| 375 | PTHS | Pelthos Therapeutics Inc. | 94.19M | -0.04% | 14,948 | 27.70M |
| 376 | QTTB | Q32 Bio Inc. | 93.26M | -3.00% | 181,037 | 53.74M |
| 377 | FBIO | Fortress Biotech, Inc. | 92.35M | 4.91% | 498,731 | 66.16M |
| 378 | ANIX | Anixa Biosciences, Inc. | 92.20M | 0.73% | 80,637 | - |
| 379 | PYPD | PolyPid Ltd. | 92.17M | -0.41% | 223,784 | - |
| 380 | ONCY | Oncolytics Biotech Inc. | 91.74M | -3.66% | 356,775 | - |
| 381 | ANVS | Annovis Bio, Inc. | 91.47M | 5.39% | 1,237,887 | - |
| 382 | ICCC | ImmuCell Corporation | 90.56M | 1.32% | 25,897 | 29.93M |
| 383 | RNTX | Rein Therapeutics Inc. | 88.96M | 7.26% | 597,027 | - |
| 384 | OKYO | OKYO Pharma Limited | 88.17M | 5.00% | 15,239 | - |
| 385 | NRXS | NeurAxis, Inc. | 85.49M | 2.48% | 79,201 | 4.28M |
| 386 | ACET | Adicet Bio, Inc. | 82.85M | 1.68% | 105,783 | - |
| 387 | CSBR | Champions Oncology, Inc. | 82.63M | -1.65% | 22,853 | 57.95M |
| 388 | RLYB | Rallybio Corporation | 81.36M | 5.49% | 68,901 | 858.00K |
| 389 | EXOZ | eXoZymes, Inc. | 79.70M | - | 3,554 | -700.00 |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 79.50M | -1.16% | 52,506 | 23.14M |
| 391 | MCRB | Seres Therapeutics, Inc. | 77.96M | 5.09% | 27,912 | 1.15M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 77.82M | -0.78% | 421,877 | - |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 76.61M | 1.70% | 355,497 | - |
| 394 | OSTX | OS Therapies Incorporated | 76.51M | -0.55% | 589,169 | - |
| 395 | HYFT | MindWalk Holdings Corp. | 76.49M | -3.14% | 796,906 | 20.70M |
| 396 | PLRX | Pliant Therapeutics, Inc. | 76.16M | 2.50% | 269,126 | - |
| 397 | XBIT | XBiotech Inc. | 75.61M | 3.77% | 23,526 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 74.64M | 6.06% | 544,480 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 69.76M | -2.11% | 21,625 | 4.43M |
| 400 | LIXT | Lixte Biotechnology Holdings, Inc. | 68.66M | 5.54% | 166,166 | - |
| 401 | IBIO | iBio, Inc. | 68.31M | 11.18% | 1,424,591 | 300.00K |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 68.26M | -2.29% | 204,565 | - |
| 403 | MNOV | MediciNova, Inc. | 67.43M | -1.44% | 19,235 | 596.64K |
| 404 | TCRX | TScan Therapeutics, Inc. | 66.66M | 2.55% | 224,232 | 9.14M |
| 405 | CUE | Cue Biopharma, Inc. | 65.43M | -1.62% | 164,734 | 32.73M |
| 406 | PDSB | PDS Biotechnology Corporation | 64.75M | 12.62% | 800,935 | - |
| 407 | IMMP | Immutep Limited | 63.02M | 2.61% | 245,755 | 5.28M |
| 408 | CING | Cingulate Inc. | 62.93M | 2.38% | 293,655 | - |
| 409 | ENTX | Entera Bio Ltd. | 62.52M | 2.42% | 37,943 | 42.00K |
| 410 | FLNA | Filana Therapeutics, Inc. | 62.32M | 3.20% | 259,022 | - |
| 411 | IMA | ImageneBio, Inc. | 62.26M | 2.03% | 21,249 | 800.00K |
| 412 | DWTX | Dogwood Therapeutics, Inc. | 60.46M | -1.63% | 33,809 | - |
| 413 | BYSI | BeyondSpring Inc. | 59.21M | - | 12,899 | 1.88M |
| 414 | ACTU | Actuate Therapeutics, Inc. | 58.38M | -2.79% | 113,193 | - |
| 415 | IBO | Impact BioMedical Inc. | 57.35M | -1.13% | 36,627 | 39.00K |
| 416 | HYPD | Hyperion DeFi, Inc. | 55.40M | 3.17% | 1,021,516 | 1.04M |
| 417 | TIL | Instil Bio, Inc. | 55.07M | 1.25% | 59,214 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 54.50M | 2.05% | 15,398 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 51.82M | -0.40% | 2,765,078 | 190.00K |
| 420 | XLO | Xilio Therapeutics, Inc. | 51.33M | 1.66% | 16,194 | 53.48M |
| 421 | RADX | Radiopharm Theranostics Limited | 50.52M | 0.44% | 19,511 | 10.86M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 49.32M | 1.55% | 220,254 | 22.33M |
| 423 | TVGN | Tevogen Bio Holdings Inc. | 48.43M | 10.35% | 23,846 | - |
| 424 | KALA | KALA BIO, Inc. | 48.33M | -1.89% | 71,504 | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 48.21M | -0.88% | 19,020 | - |
| 426 | PSTV | Plus Therapeutics, Inc. | 47.28M | 7.15% | 286,104 | 5.18M |
| 427 | GOSS | Gossamer Bio, Inc. | 47.15M | -6.69% | 36,707,106 | 55.54M |
| 428 | QNTM | Quantum BioPharma Ltd. | 46.49M | - | 478,817 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -0.76% | 86,433 | - |
| 430 | MREO | Mereo BioPharma Group plc | 43.43M | -3.75% | 1,620,966 | 500.00K |
| 431 | ATOS | Atossa Therapeutics, Inc. | 42.80M | 2.69% | 54,945 | - |
| 432 | NTRB | Nutriband Inc. | 42.42M | -1.13% | 9,247 | 2.04M |
| 433 | OTLK | Outlook Therapeutics, Inc. | 40.25M | 21.98% | 19,516,079 | 333.14K |
| 434 | LITS | Lite Strategy, Inc. | 40.00M | -1.34% | 274,391 | - |
| 435 | RNXT | RenovoRx, Inc. | 39.72M | 8.83% | 489,182 | 1.49M |
| 436 | INMB | INmune Bio Inc. | 38.28M | 2.13% | 252,131 | 50.00K |
| 437 | LTRN | Lantern Pharma Inc. | 37.21M | 4.73% | 245,223 | - |
| 438 | NXTC | NextCure, Inc. | 36.80M | 5.70% | 49,747 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | 0.85% | 79,656 | 90.00K |
| 440 | DARE | Daré Bioscience, Inc. | 36.10M | 3.43% | 186,980 | 1.16M |
| 441 | VERU | Veru Inc. | 35.63M | 2.30% | 24,689 | 16.89M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 35.33M | 1.96% | 84,704 | 4.71M |
| 443 | NNVC | NanoViricides, Inc. | 35.31M | -4.32% | 565,679 | - |
| 444 | GRCE | Grace Therapeutics, Inc. | 34.66M | 2.75% | 191,187 | - |
| 445 | EVAX | Evaxion A/S | 33.86M | 1.50% | 23,515 | 7.53M |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 33.68M | -6.75% | 58,585 | - |
| 447 | BOLD | Boundless Bio, Inc. | 32.51M | 2.11% | 39,609 | - |
| 448 | APLM | Apollomics, Inc. | 31.42M | 5.76% | 20,582 | 8.84M |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 30.65M | 0.42% | 246,898 | 38.00K |
| 450 | BRNS | Barinthus Biotherapeutics plc | 28.63M | 2.02% | 11,888 | 14.97M |
| 451 | CRVO | CervoMed Inc. | 28.61M | -4.63% | 68,758 | 2.09M |
| 452 | GRDX | GridAI Technologies Corp. | 28.58M | 20.05% | 169,047 | - |
| 453 | IGC | IGC Pharma, Inc. | 28.54M | 2.81% | 265,404 | 1.11M |
| 454 | LSTA | Lisata Therapeutics, Inc. | 28.36M | -1.26% | 3,847 | 170.00K |
| 455 | SER | Serina Therapeutics, Inc. | 28.11M | 11.00% | 108,202 | 130.00K |
| 456 | KYNB | Kyntra Bio, Inc. | 28.09M | -0.14% | 5,701 | 7.44M |
| 457 | NEUP | Neuphoria Therapeutics Inc. | 27.60M | 3.85% | 65,697 | -13.27K |
| 458 | ABVC | ABVC BioPharma, Inc. | 27.43M | 0.91% | 118,692 | 797.92K |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 27.33M | -4.56% | 44,618 | - |
| 460 | PTN | Palatin Technologies, Inc. | 27.29M | -1.10% | 6,512 | 12.88M |
| 461 | DYAI | Dyadic International, Inc. | 26.96M | 0.33% | 22,212 | 3.81M |
| 462 | BCTX | BriaCell Therapeutics Corp. | 26.56M | -4.12% | 196,977 | - |
| 463 | TPST | Tempest Therapeutics, Inc. | 25.96M | -2.69% | 59,207 | - |
| 464 | CELU | Celularity Inc. | 25.91M | 8.89% | 201,448 | 26.55M |
| 465 | ALLR | Allarity Therapeutics, Inc. | 25.66M | 11.41% | 572,058 | 345.00K |
| 466 | CLRB | Cellectar Biosciences, Inc. | 25.33M | - | 146,735 | - |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 25.24M | -0.42% | 260,422 | 789.00K |
| 468 | SKYE | Skye Bioscience, Inc. | 25.11M | -7.06% | 179,584 | - |
| 469 | JSPR | Jasper Therapeutics, Inc. | 24.43M | 0.02% | 99,330 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 23.84M | 1.42% | 60,601 | 3.55M |
| 471 | PLRZ | Polyrizon Ltd. | 23.68M | -6.64% | 23,782 | - |
| 472 | SNSE | Sensei Biotherapeutics, Inc. | 23.54M | -0.11% | 15,960 | - |
| 473 | PLUR | Pluri Inc. | 23.12M | -11.54% | 27,350 | 1.08M |
| 474 | VYNE | VYNE Therapeutics Inc. | 22.59M | 0.19% | 95,872 | 454.00K |
| 475 | TRAW | Traws Pharma, Inc. | 22.57M | -8.02% | 927,004 | 2.73M |
| 476 | AEON | AEON Biopharma, Inc. | 21.60M | -4.83% | 38,474 | - |
| 477 | LGVN | Longeveron Inc. | 21.11M | 2.07% | 818,251 | 1.22M |
| 478 | CVM | CEL-SCI Corporation | 21.01M | -8.81% | 422,725 | - |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 20.53M | -3.56% | 416,714 | 1.14M |
| 480 | CRIS | Curis, Inc. | 19.59M | -1.05% | 228,032 | 7.06M |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 18.25M | 16.05% | 995,691 | 5.61M |
| 482 | KTTA | Pasithea Therapeutics Corp. | 17.98M | -0.14% | 120,757 | - |
| 483 | LPCN | Lipocine Inc. | 17.82M | -0.89% | 54,605 | 2.00M |
| 484 | XCUR | Exicure, Inc. | 17.59M | -7.69% | 12,728 | 500.00K |
| 485 | QNCX | Quince Therapeutics, Inc. | 17.44M | -0.93% | 1,201,370 | - |
| 486 | HCWB | HCW Biologics Inc. | 17.37M | 6.17% | 21,066,626 | 6.59M |
| 487 | NCEL | NewcelX Ltd. | 17.12M | -2.15% | 2,588 | - |
| 488 | OSRH | OSR Holdings, Inc. | 16.90M | 2.02% | 812,324 | 2.63M |
| 489 | PASG | Passage Bio, Inc. | 16.55M | -0.77% | 22,150 | - |
| 490 | INAB | IN8bio, Inc. | 16.54M | 7.01% | 112,298 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 15.91M | 0.19% | 40,048 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 15.83M | -0.25% | 44,258 | 1.44M |
| 493 | HIND | Vyome Holdings, Inc. | 15.65M | 5.69% | 33,066 | 152.72K |
| 494 | COCP | Cocrystal Pharma, Inc. | 15.58M | 1.80% | 42,891 | 225.00K |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.01M | 4.14% | 106,596 | 368.00K |
| 496 | MTVA | MetaVia Inc. | 14.82M | -0.69% | 5,262,476 | - |
| 497 | ERNA | Ernexa Therapeutics Inc. | 14.53M | 9.30% | 179,360 | 1,000.00 |
| 498 | GDTC | CytoMed Therapeutics Limited | 14.44M | -7.58% | 9,422 | 669.28K |
| 499 | GNTA | Genenta Science S.p.A. | 13.92M | -4.56% | 29,435 | - |
| 500 | GTBP | GT Biopharma, Inc. | 13.66M | 3.27% | 944,313 | - |